RecruitingNot ApplicableNCT06529978

Endocardial Mapping With the CoreMap EP Mapping System

Endocardial Mapping With the CoreMap Electrophysiology Mapping System for Persistent Atrial Fibrillation Protocol


Sponsor

CoreMap Inc.

Enrollment

245 participants

Start Date

Jul 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a global, multi-site, prospective, feasibility study.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a new mapping system (called CoreMap EP) that helps doctors identify the abnormal electrical patterns in the heart that cause atrial fibrillation (AFib) — an irregular heartbeat. The system is used during a standard AFib ablation procedure (a treatment that destroys the tissue causing the abnormal rhythm). **You may be eligible if...** - You are between 18 and 80 years old - You have persistent or long-standing persistent atrial fibrillation (AFib that does not stop on its own) - You are already scheduled for a clinically recommended AFib ablation procedure - You are able to give written informed consent **You may NOT be eligible if...** - You have a different type of AFib (e.g., paroxysmal AFib, which comes and goes) - You are not scheduled for an ablation procedure - You have conditions that make ablation unsafe - You are outside the age range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECoreMap EP Mapping System Mapping

Endocardial mapping to collect and analyze high fidelity endocardial EGMs in patients with persistent and long-standing persistent AF.

DEVICECoreMap EP Mapping System Map-Guided Ablation

Initial development and evaluation of a map-guided tailored ablation strategy and to demonstrate safety and chronic efficacy of the CoreMap EP Mapping System.


Locations(3)

NCH Downtown Baker Hospital

Naples, Florida, United States

University of Vermont Medical Center

Burlington, Vermont, United States

Na Homolce Hospital

Praha Klanovice, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06529978


Related Trials